中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2009年
3期
50-51
,共2页
郎新玲%孙毅%郭丽华%许锦姬%黄卫东
郎新玲%孫毅%郭麗華%許錦姬%黃衛東
랑신령%손의%곽려화%허금희%황위동
支气管哮喘%嗜酸性粒细胞趋化蛋白%酶联免疫吸附试验
支氣管哮喘%嗜痠性粒細胞趨化蛋白%酶聯免疫吸附試驗
지기관효천%기산성립세포추화단백%매련면역흡부시험
Bronchus Asthma%Eotaxin%ELISA
目的探讨支气管哮喘患儿嗜酸性粒细胞趋化蛋白(Eotaxin)水平的变化及临床意义.方法随机选择哮喘专科收治的哮喘患儿急性发作期35例、缓解期25例、正常对照组25例,采用酶联免疫吸附试验(ELISA)测定3组血清Eotaxin水平.结果急性发作组较缓解组、正常对照组明显升高(P<0.01),缓解组与对照组无显著差异.急性发作组中重度发作组明显高于轻中度组(P<0.01).结论Eotaxin水平与哮喘病情变化一致,可以用来监测哮喘的气道炎症状况,判断治疗效果及预后.
目的探討支氣管哮喘患兒嗜痠性粒細胞趨化蛋白(Eotaxin)水平的變化及臨床意義.方法隨機選擇哮喘專科收治的哮喘患兒急性髮作期35例、緩解期25例、正常對照組25例,採用酶聯免疫吸附試驗(ELISA)測定3組血清Eotaxin水平.結果急性髮作組較緩解組、正常對照組明顯升高(P<0.01),緩解組與對照組無顯著差異.急性髮作組中重度髮作組明顯高于輕中度組(P<0.01).結論Eotaxin水平與哮喘病情變化一緻,可以用來鑑測哮喘的氣道炎癥狀況,判斷治療效果及預後.
목적탐토지기관효천환인기산성립세포추화단백(Eotaxin)수평적변화급림상의의.방법수궤선택효천전과수치적효천환인급성발작기35례、완해기25례、정상대조조25례,채용매련면역흡부시험(ELISA)측정3조혈청Eotaxin수평.결과급성발작조교완해조、정상대조조명현승고(P<0.01),완해조여대조조무현저차이.급성발작조중중도발작조명현고우경중도조(P<0.01).결론Eotaxin수평여효천병정변화일치,가이용래감측효천적기도염증상황,판단치료효과급예후.
Objective To evaluate clinical applications of Eotaxin level in asthma children serum.Methods Randomly chosen from January 2006 to January 2007 in asthma specialty of Maternal and Child Healthcare Hospital of Baoan, asthmatic acute attack patients are 35 cases, athmatic remission are 25 cases, and normal control group are 25 cases. Enzyme-linked immunosorbent test (ELISA) is used to measure Eotaxin level in 3 groups of serum. Results The Eotaxin level of athmatic acute attack group is significantly higher than that of athmatic remission group and normal control group(P<0.01). The Eotaxin level of athmatic remission group had no significant difference with the control group. The Eotaxin level of severe attack group is obviously higher than mild-to-moderate group (P<0.01. Conclusion Eotaxin level changes according to asthma condition,which can be used to monitor the airway inflammation,judge therapeutic effect and prognosis.